NuCana (NuCana) Beginning Cash Position : $21.89 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is NuCana Beginning Cash Position?

NuCana's Beginning Cash Position for the quarter that ended in Mar. 2024 was $21.89 Mil.

NuCana's quarterly Beginning Cash Position declined from Sep. 2023 ($30.50 Mil) to Dec. 2023 ($22.54 Mil) and declined from Dec. 2023 ($22.54 Mil) to Mar. 2024 ($21.89 Mil).

NuCana's annual Beginning Cash Position declined from Dec. 2021 ($116.16 Mil) to Dec. 2022 ($73.40 Mil) and declined from Dec. 2022 ($73.40 Mil) to Dec. 2023 ($53.05 Mil).

NuCana Beginning Cash Position Historical Data

The historical data trend for NuCana's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuCana Beginning Cash Position Chart

NuCana Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

100.88

69.84

116.16

73.40

53.05

NuCana Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															50.86	39.14	30.50	22.54	21.89

NuCana Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

NuCana Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of NuCana's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

NuCana (NuCana) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N04A:Germany

Address

3 Lochside Way, Edinburgh, GBR, EH12 9DT

Website

https://www.nucana.com

NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.